← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Mesoblast MESO $1.79B	72	+3	+4%	$53.3M
52	52 ProKidney PROK $307M	71	0	0%	$99.5M
53	53 enGene Therapeutics ENGN $105M	60	-2	-3%	$86.5M
54	54 TScan Therapeutics TCRX $14.3M	60	0	0%	$35.1M
55	55 Adicet Bio ACET $45.8M	56	+7	+14%	$52.8M
56	56 Fortress Biotech FBIO $63.4M	55	+3	+6%	$17.7M
57	57 Coya Therapeutics COYA $98.1M	54	-2	-4%	$45.5M
58	GRML 58 Greenland Mines Ltd GRML $86.6M	47	+22	+88%	$4.97M
59	59 Metagenomi Therapeutics MGX $32.5M	43	-5	-10%	$7.45M
60	60 Celularity CELU $42.5M	39	+1	+3%	$2.44M
61	LGVN 61 Longeveron LGVN $5.52M	39	+9	+30%	$3.35M
62	62 Atara Biotherapeutics ATRA $96M	36	+3	+9%	$51.3M
63	63 Marker Therapeutics MRKR $14.8M	35	0	0%	$5.84M
64	64 Passage Bio PASG $11.8M	29	-6	-17%	$6.82M
65	65 PharmaCyte Biotech PMCB $3.74M	28	-4	-13%	$586K
66	66 Cellectis CLLS $113M	27	-5	-16%	$28.4M
67	67 MiNK Therapeutics INKT $52.8M	27	+4	+17%	$2.39M
68	68 Instil Bio TIL $40.4M	26	-6	-19%	$29.2M
69	69 Enlivex Ltd ENLV $4.29M	24	-10	-29%	$2.34M
70	70 Imunon IMNN $5.84M	23	+4	+21%	$754K
71	71 Mustang Bio MBIO $2.8M	23	+1	+5%	$378K
72	72 Calidi Biotherapeutics CLDI $2.26M	22	-5	-19%	$89.3K
73	73 BioCardia BCDA $14M	21	+3	+17%	$1.65M
74	74 IN8bio INAB $11.8M	21	+2	+11%	$5.35M
75	75 Senti Biosciences Holdings SNTI $7.5M	20	+4	+25%	$6.37M